Lactation drug could reduce breast cancer risk after childbirth, study suggests
An international team of scientists has found that a lactation drug could reduce the risk of breast cancer in mothers after childbirth. Cabergoline, a medication used to stop milk production after pregnancy loss or when breastfeeding is not possible, is generally well tolerated by patients with few
<p>An international team of scientists has found that a lactation drug could reduce the risk of breast cancer in mothers after childbirth. Cabergoline, a medication used to stop milk production after pregnancy loss or when breastfeeding is not possible, is generally well tolerated by patients with few </p>